Varicella zoster virus vaccine - Shanghai Zerun Biotechnology Co
Alternative Names: Herpes zoster vaccine - Shanghai Zerun Biotechnology CoLatest Information Update: 10 Mar 2023
At a glance
- Originator Shanghai Zerun Biotechnology Co
- Class Synthetic vaccines; Varicella vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Herpes zoster
Most Recent Events
- 27 Feb 2023 Preclinical trials in Herpes zoster vaccine (Prevention) in China (Parenteral) prior to February 2023 (Shanghai Zerun Biotechnology Co pipeline, February 2023)